Immunic, Inc. (NASDAQ:IMUX – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are ...

Immunic, Inc. to Participate in Scientific and Industry Conferences in April ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

Immunic (IMUX – Research Report) received a Buy rating and a $1.20 price target from William Blair analyst Matt Phipps yesterday. The company’s ...

Lundin Mining Announces New Shareholder Distribution Policy; Adjusting Quarterly Dividend to C$0.0275/Share From C$0.09/Share; Allocating Up to Around $150M Per Year in Share Buybacks; Committed to ...

Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

Immunic (NASDAQ:IMUX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to ...

NeueHealth Inc (NEUE) is expected to report for 4Q. NeuroMetrix Inc (NURO) is expected to report for 4Q. Nikola Corp (NKLAQ) is expected to report for 4Q. Nu Ride Inc (NRDE) is expected to report for ...